Therapy News and Research

RSS

Malaria protein could one day help stop cancer

Scientists at the University of British Columbia, Vancouver Coastal Health and the BC Cancer Agency have discovered a protein from malaria that could one day help stop cancer in its tracks.

13 Oct 2015

ViewRay selected as recipient of 2015 Frost & Sullivan Technology Innovation Leadership Award

ViewRay, Inc. announced today that the company has been selected to receive the 2015 Frost & Sullivan Technology Innovation Leadership Award, a prestigious recognition based on an extensive and independent Frost & Sullivan analysis of the North American Image-Guided Radiation Therapy market.

13 Oct 2015

Lilly, ImaginAb partner to study potential novel T-cell-based immuno-oncology therapies

Eli Lilly and Company and ImaginAb Inc. are pleased to announce a preclinical research collaboration to study potential novel T-cell-based immuno-oncology therapies.

13 Oct 2015

SMC approves Bayer's Xofigo for treatment of castration-resistant prostate cancer in NHS Scotland

The Scottish Medicines Consortium has today announced that Xofigo has been accepted for use within NHS Scotland for the treatment of adult patients with castration-resistant prostate cancer, symptomatic bone metastases and no known visceral metastases.

13 Oct 2015

Quest Diagnostics provides Dako’s PD-L1 complementary diagnostic test for non-squamous non-small cell carcinoma

Quest Diagnostics, the world's leading provider of diagnostic information services, today announced that it now provides clinical laboratory testing using the PD-L1 IHC 28-8 pharmDx immunohistochemistry test, available through Dako, an Agilent Technologies company.

From Quest Diagnostics 13 Oct 2015

Men on effective HIV therapy less likely to get HBV infection, shows research

Previous studies of individuals with HIV have suggested that HIV drug regimens that included drugs active against hepatitis B virus (HBV) can decrease the risk of infection with the liver-damaging HBV.

13 Oct 2015

Study: RNA editing technique shows promise in treating rare, severe form of muscular dystrophy

An RNA editing technique called "exon skipping" has shown preliminary success in treating a rare and severe form of muscular dystrophy that currently has no treatment, based on a new study from Northwestern Medicine and the University of Chicago. Children with the disease lose significant muscle strength early in life.

13 Oct 2015

Penn researchers show that canine X-linked retinitis pigmentosa can be cured over the long term

Three years ago, a team from the University of Pennsylvania announced that they had cured X-linked retinitis pigmentosa, a blinding retinal disease, in dogs. Now they've shown that they can cure the canine disease over the long term, even when the treatment is given after half or more of the affected photoreceptor cells have been destroyed.

13 Oct 2015

Research: Epigenetic factor reduces sensitivity of breast cancer cells to common cancer drug

A surprising, paradoxical relationship between a tumor suppressor molecule and an oncogene may be the key to explaining and working around how breast cancer tumor cells become desensitized to a common cancer drug, found researchers at the Perelman School of Medicine at the University of Pennsylvania.

13 Oct 2015

Elekta’s high field MRI-guided linear accelerator installed at MD Anderson Cancer Center

The University of Texas MD Anderson Cancer Center, Elekta and Philips teams recently completed installation of the first high field (1.5 Tesla) MRI-guided linear accelerator in the United States.

From Elekta 13 Oct 2015

Females with mild closed-head brain injury more likely to misuse alcohol later in life

Girls who suffer a concussive bump on the head in childhood could be at increased risk for abusing alcohol as adults, a new study suggests.

13 Oct 2015

Loyola University successfully performs double-lung transplant in patient with debilitating lung disease

Before he developed a debilitating lung disease, outdoorsman Michael Olson had taken 57 canoe and fishing trips to Canada.

13 Oct 2015

ATA announces first-year research grants to support promising young researchers

The American Thyroid Association (ATA) is pleased to announce the awarding of first-year grants to support two young researchers selected from among a pool of applicants who proposed projects that will contribute novel insights and information with the potential to lead to new drug targets and therapeutic strategies to improve the treatment of thyroid cancer and patient outcomes.

13 Oct 2015

Small heat shock protein as model for Alzheimer’s medication

In Alzheimer’s disease proteins clump together to long fibrils causing the death of nerve cells. Small heat shock proteins can counteract this effect. Scientists, therefore, hope to deploy them as agents in the treatment of neurodegenerative diseases. Using the example of a small heat shock protein, researchers at the Technical University of Munich (TUM) and the Helmholtz Zentrum München have now uncovered how the protein interacts with other proteins.

13 Oct 2015

Study identifies four distinct types of bowel cancer

Bowel cancer can be divided up into four distinct diseases, each with its own set of biological characteristics, a major new study reports.

12 Oct 2015

Rebiotix's RBX2660 receives FDA Breakthrough Therapy designation for treatment of recurrent C diff infection

Rebiotix Inc. today announced that U.S. Food and Drug Administration has designated its lead Microbiota Restoration Therapy (MRT) RBX2660 as a Breakthrough Therapy for the treatment of recurrent Clostridium difficile (C diff) infection, a challenging to treat gastrointestinal (GI) infection that causes 29,000 deaths in the U.S. annually.

12 Oct 2015

Varian Medical Systems' ProBeam proton therapy system receives CE Mark approval

Varian Medical Systems has received CE Mark for its latest ProBeam proton therapy system. The CE Mark allows Varian to begin installation of the newest version of its ProBeam system in the European Union.

12 Oct 2015

Presenting and discussing menu of treatment options good for patients, physicians

Presenting and discussing a menu of treatment options is good for both the patient and the physician according to Regenstrief Institute and VA Center for Health Communication and Information investigator Kurt Kroenke, M.D., writing in a commentary in the Sept. 28 issue of JAMA Internal Medicine.

12 Oct 2015

Researchers find protein that plays crucial role in development of allergic airway inflammation

Allergies are becoming more commonplace, particularly in industrialised coun-tries. In addition to hay fever, allergic asthma is currently considered to be one of the most widespread allergies. UFZ researchers and their colleagues from the University of Leipzig have recently been successful in finding a protein that plays a critical role in the development of allergic airway inflammation.

12 Oct 2015

Pioneering surgical technique restores hand and arm movement to quadriplegic patients

A pioneering surgical technique has restored some hand and arm movement to patients immobilized by spinal cord injuries in the neck, reports a new study at Washington University School of Medicine in St. Louis.

12 Oct 2015

Therapy News and Research

Malaria protein could one day help stop cancer

ViewRay selected as recipient of 2015 Frost & Sullivan Technology Innovation Leadership Award

Lilly, ImaginAb partner to study potential novel T-cell-based immuno-oncology therapies

SMC approves Bayer's Xofigo for treatment of castration-resistant prostate cancer in NHS Scotland

Quest Diagnostics provides Dako’s PD-L1 complementary diagnostic test for non-squamous non-small cell carcinoma

Men on effective HIV therapy less likely to get HBV infection, shows research

Study: RNA editing technique shows promise in treating rare, severe form of muscular dystrophy

Penn researchers show that canine X-linked retinitis pigmentosa can be cured over the long term

Research: Epigenetic factor reduces sensitivity of breast cancer cells to common cancer drug

Elekta’s high field MRI-guided linear accelerator installed at MD Anderson Cancer Center

Females with mild closed-head brain injury more likely to misuse alcohol later in life

Loyola University successfully performs double-lung transplant in patient with debilitating lung disease

ATA announces first-year research grants to support promising young researchers

Small heat shock protein as model for Alzheimer’s medication

Study identifies four distinct types of bowel cancer

Rebiotix's RBX2660 receives FDA Breakthrough Therapy designation for treatment of recurrent C diff infection

Varian Medical Systems' ProBeam proton therapy system receives CE Mark approval

Presenting and discussing menu of treatment options good for patients, physicians

Researchers find protein that plays crucial role in development of allergic airway inflammation

Pioneering surgical technique restores hand and arm movement to quadriplegic patients

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News